Trials / Completed
CompletedNCT00649506
Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg
Single-Dose Food In Relative Bioavailability Study of Mylan Nitrofurantoin Macrocrystals 100 mg Capsules and Procter & Gamble Macrodantin® 100 mg Capsules in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Mylan Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to evaluate the relative bioavailability of Mylan's nitrofurantoin macrocrystals 100 mg capsules to Procter \& Gamble's Macrodantin® 100 mg capsules following a single, oral 100 mg (1 x 100 mg) dose in 28 healthy, adult, non-tobacco using volunteers under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitrofurantoin Macrocrystals 100 mg Capsules | 100mg, single dose fed |
| DRUG | Macrodantin® 100 mg Capsules | 100mg, single dose fed |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2003-09-01
- Completion
- 2003-09-01
- First posted
- 2008-04-01
- Last updated
- 2024-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00649506. Inclusion in this directory is not an endorsement.